Our subsequent integrative transcriptome analysis shed further light on the link between impairment of TFIIH-mediated functions in placenta and induction of molecular mediators of clinical symptoms of preeclampsia through dysregulation of EGFR- and ATF3-dependent pathways [19]. Here, ERCC2 is linked to preeclampsia.